Home › NDC Lookup › RxCUI directory › RxCUI 2664065

50 ML fosaprepitant 3 MG/ML Injection — RxCUI 2664065

Name: 50 ML fosaprepitant 3 MG/ML Injection (RxCUI 2664065)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2664065 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2664065

Official name50 ML fosaprepitant 3 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asfosaprepitant 150 MG per 50 ML Injection; fosaprepitant 150 MG in 50 ML Injection

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)1,538 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fosaprepitant Dimeglumine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Fosaprepitant is an anti-nausea medicine given by IV infusion before chemotherapy starts. Chemo can trigger powerful nausea signals in your brain — both right away and in the days...
What exactly is this medication, and why am I getting it before chemo?
Most people tolerate the infusion well. The most commonly reported side effects include fatigue, diarrhea, and weakness — though it's worth noting that the chemotherapy itself also...
Will I feel anything during the infusion? What side effects should I expect?

📖 Read our full Fosaprepitant Dimeglumine guide →

🕸️ Concept Web — How 50 ML fosaprepitant 3 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 50 ML fosaprepitant 3 MG/ML Injection RxCUI 2664065 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Fosaprepitant 1731071 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Focinvez 2664067 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Fosaprepitant Injection 1731074 SCDF
- Fosaprepitant Injectable Product 1731073 SCDG
- Fosaprepitant Injection [Focinvez] 2664070 SBDF
- Focinvez Injectable Product 2664069 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Fosaprepitant 3 MG/ML 2664064 SCDC
- 50 ML fosaprepitant 3 MG/ML Injection [Focinvez] 2664071 SBD
- Fosaprepitant 3 MG/ML [Focinvez] 2664068 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Fosaprepitant 3 MG/ML SCDC · 2664064
Fosaprepitant Injection SCDF · 1731074
Fosaprepitant Injectable Product SCDG · 1731073

Brand-Name Concepts

50 ML fosaprepitant 3 MG/ML Injection [Focinvez] SBD · 2664071
Fosaprepitant 3 MG/ML [Focinvez] SBDC · 2664068
Fosaprepitant Injection [Focinvez] SBDF · 2664070
Focinvez Injectable Product SBDG · 2664069
Focinvez BN · 2664067

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2664065 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70121-2631-01	1 VIAL, SINGLE-DOSE in 1 CARTON (70121-2631-1) / 50 mL in 1...	FOCINVEZ	Amneal Pharmaceuticals LLC	2024-06-15
82449-0231-01	1 VIAL, SINGLE-DOSE in 1 CARTON (82449-231-01) / 50 mL in 1...	FOCINVEZ	Steriscience Specialties Private Limited	2024-06-26

Observed labelers: Amneal Pharmaceuticals LLC (1) · Steriscience Specialties Private Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1434	Inj, focinvez, 1mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.